Genentech, the National Institute of Health (NIH) and the Banner Alzheimer’s Institute have partnered to carry out the first-ever study of healthy individuals. In this study, 300 members of distantly related families in Colombia who share a rare gene mutation that triggers Alzheimer’s disease (AD) in early life, with initial symptoms appearing around the age of 45. A small number of US citizens will also be included in this study.

This study is the first of its kind, in that it will examine patients before they show any symptoms of cognitive decline. Continue reading →